A decade-long study from Bengaluru's Jayadeva Institute highlights heart disease risks in HIV patients, gaining global recognition at TCT 2025.

The American Heart Association reveals that viral infections such as Covid-19 and the flu can significantly raise your risk ...

More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...

After winning accolades in the US for his outstanding research, Xie’s work will continue to focus on effective mRNA-based ...

UN World Children's Day on Nov 20 is an annual reminder that every child deserves the chance not just to survive, but to ...

The endocannabinoid system is one of the most diffuse neurotransmitter systems in the body and the brain. Understanding its ...

GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit ...

T he Trump administration is recurrently cutting basic research funding and disrupting the U.S. science and technology (S&T) ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

Researchers at La Jolla Institute for Immunology, Scripps Research, and the Ragon Institute of MGH, MIT, and Harvard report coordinated studies showing that several HIV germline-targeting immunogens ...

The drug, Lenacapavir, is the world's first injectable Pre-Exposure Prophylaxis (PrEP). According to the World Health ...

South Africa has become the first African country – and our medicines regulator the third worldwide – to register the ...